SHIFT Newsroom · GLOBAL
Trial record: CagriSema doses compared with semaglutide
Registry status checked on 3 October 2026: recruiting.
ClinicalTrials.gov lists NCT07564414, concerning CagriSema doses compared with semaglutide, as recruiting. The record was first posted on 2026-05-04 and last updated on 2026-09-30; SHIFT checked it on 3 October 2026.
The registration describes a research question and protocol, not proof that the intervention is effective or suitable for an individual.
No results tables were posted in this registry record when checked. That does not establish that no results have been published elsewhere. A registry entry is not a UK marketing authorisation or confirmation of NHS access.
SHIFT’s take
Keep the trial status, published results and UK treatment access separate. Do not change treatment on the basis of a registration.